Kiniksa Pharmaceuticals International (KNSA) Free Cash Flow Growth (3y) (2020 - 2026)
Kiniksa Pharmaceuticals International (KNSA) Free Cash Flow Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 9.86% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -18.92% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 2.82% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 45.60% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 39.19% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -82.02% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 18.94% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 114.21% |
| 10 | Kiniksa Pharmaceuticals International | 3.79 Bn | 3.32 Bn | 193.47 Mn | 139.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 139.13% |
| Dec 31, 2025 | 88.92% |
| Sep 30, 2025 | -18.91% |
| Jun 30, 2025 | 77.07% |
| Mar 31, 2025 | 37.59% |
| Dec 31, 2024 | 43.86% |
| Sep 30, 2024 | 57.22% |
| Jun 30, 2024 | 28.74% |
| Mar 31, 2024 | 27.99% |
| Dec 31, 2023 | 28.13% |
| Sep 30, 2023 | 35.62% |
| Jun 30, 2023 | 49.44% |
| Mar 31, 2023 | 48.83% |
| Dec 31, 2022 | 20.74% |
| Sep 30, 2022 | 59.43% |
| Jun 30, 2022 | 42.13% |
| Mar 31, 2022 | 17.16% |
| Dec 31, 2021 | 15.64% |
| Sep 30, 2021 | -10.39% |
| Jun 30, 2021 | -28.86% |